CN102048151A - 一种滋身养气功能的保健胶囊及其制备方法 - Google Patents
一种滋身养气功能的保健胶囊及其制备方法 Download PDFInfo
- Publication number
- CN102048151A CN102048151A CN2009102726498A CN200910272649A CN102048151A CN 102048151 A CN102048151 A CN 102048151A CN 2009102726498 A CN2009102726498 A CN 2009102726498A CN 200910272649 A CN200910272649 A CN 200910272649A CN 102048151 A CN102048151 A CN 102048151A
- Authority
- CN
- China
- Prior art keywords
- health
- american ginseng
- matrimony vine
- fructus
- percent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title claims abstract description 6
- 240000005373 Panax quinquefolius Species 0.000 claims abstract description 25
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 25
- 239000002994 raw material Substances 0.000 claims abstract description 21
- 238000002156 mixing Methods 0.000 claims abstract description 8
- 244000241838 Lycium barbarum Species 0.000 claims description 30
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 30
- 241001248610 Ophiocordyceps sinensis Species 0.000 claims description 21
- 238000004108 freeze drying Methods 0.000 claims description 7
- 230000001954 sterilising effect Effects 0.000 claims description 7
- 238000004659 sterilization and disinfection Methods 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 27
- 230000006870 function Effects 0.000 abstract description 9
- 230000036039 immunity Effects 0.000 abstract description 8
- 241000427159 Achyranthes Species 0.000 abstract description 4
- 210000004556 brain Anatomy 0.000 abstract description 4
- 230000000295 complement effect Effects 0.000 abstract description 4
- 241000233866 Fungi Species 0.000 abstract description 3
- 240000001307 Myosotis scorpioides Species 0.000 abstract description 3
- 244000241872 Lycium chinense Species 0.000 abstract 2
- 235000015468 Lycium chinense Nutrition 0.000 abstract 2
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 abstract 1
- 230000003796 beauty Effects 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 230000007774 longterm Effects 0.000 abstract 1
- 210000005036 nerve Anatomy 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 239000003814 drug Substances 0.000 description 9
- 230000036541 health Effects 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 6
- 230000003203 everyday effect Effects 0.000 description 5
- 235000019580 granularity Nutrition 0.000 description 5
- 238000005303 weighing Methods 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000000116 mitigating effect Effects 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- 230000002929 anti-fatigue Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000000857 drug effect Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 230000003340 mental effect Effects 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000000496 anti-anoxic effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- VFPFQHQNJCMNBZ-UHFFFAOYSA-N ethyl gallate Chemical compound CCOC(=O)C1=CC(O)=C(O)C(O)=C1 VFPFQHQNJCMNBZ-UHFFFAOYSA-N 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 230000036433 growing body Effects 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000011946 reduction process Methods 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- YGVHOSGNOYKRIH-UHFFFAOYSA-N 1,3,6-tri-O-galloyl-2,4-O-chebuloyl-beta-D-glucopyranose Natural products O1C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(C2OC(=O)C=3C=C(O)C(O)=C(O)C=3)OC(=O)C(C3=4)=CC(O)=C(O)C=4OC(=O)C(O)C3C(CC(O)=O)C(=O)OC2C1COC(=O)C1=CC(O)=C(O)C(O)=C1 YGVHOSGNOYKRIH-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- YGVHOSGNOYKRIH-FJPMMHPYSA-N Chebulinic acid Chemical compound C([C@@H]1[C@H]2OC(=O)[C@@H](CC(O)=O)[C@@H]3[C@@H](C(OC=4C(O)=C(O)C=C(C3=4)C(=O)O[C@@H]([C@H](OC(=O)C=3C=C(O)C(O)=C(O)C=3)O1)[C@H]2OC(=O)C=1C=C(O)C(O)=C(O)C=1)=O)O)OC(=O)C1=CC(O)=C(O)C(O)=C1 YGVHOSGNOYKRIH-FJPMMHPYSA-N 0.000 description 1
- MHDANAFDVQLLPY-UHFFFAOYSA-N Chebulinic acid Natural products OC(C1C(CC(=O)O)C(=O)OC2C(COC(=O)c3cc(O)c(O)c(O)c3)OC(OC(=O)c4cc(O)c(O)c(O)c4)C(OC(=O)c5cc(O)c(O)c(O)c15)C2OC(=O)c6cc(O)c(O)c(O)c6)C(=O)O MHDANAFDVQLLPY-UHFFFAOYSA-N 0.000 description 1
- 229920000585 Chebulinic acid Polymers 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 230000000680 avirulence Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- UGIVASYMZSZAMP-UHFFFAOYSA-N chebulagic acid Natural products OC1C2c3c(OC1=O)c(O)c(O)cc3C(=O)OC4C(OC(=O)c5cc(O)c(O)c(O)c5)OC6COC(=O)c7cc(O)c(O)c(O)c7c8c(O)c(O)c(O)cc8C(=O)OC4C6OC(=O)C2(O)C(=O)O UGIVASYMZSZAMP-UHFFFAOYSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 235000008729 phenylalanine Nutrition 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000014393 valine Nutrition 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明涉及一种保健胶囊,具体地说是一种滋身养气功能的保健胶囊及其制备方法。它是下述原料按质量百分比混合制备而成:冬虫夏草5~15%,西洋参10~20%,红枣10~40%,枸杞10~40%,毛诃子5~10%,怀牛膝10~15%。本发明将冬虫夏草、西洋参、红枣、枸杞、毛诃子、怀牛膝六味原料,科学搭配组方无任何毒副作用和刺激性,经组合搭配后的作用相辅相成,使其中的有效成分发挥更佳效果,可长期服用,滋身养气、增加人体免疫力、健脑安神、美容养颜。
Description
技术领域
本发明涉及一种保健胶囊,具体地说是一种滋身养气功能的保健胶囊及其制备方法。
背景技术
随着经济的发展,生活水平的不断提高,人们对自身健康的要求也越发明显,但由于工作压力的增大,加上饮食失衡、睡眠质量下降等原因,越来越多的人群处于亚健康状态。因此滋身养气、增加人体免疫力、健脑安神以及美容养颜功效的保健品就备受欢迎。
冬虫夏草含有多种营养物质,主要成分有:虫草酸、粗蛋白和谷氨酸、苯丙氨酸、缬氨酸、精氨酸、丙氨酸和饱和脂肪酸、不饱和脂肪酸及维生素B12等物质。虫草的功能为增强人体免疫力,补虚损,益精气。补肺益肾,治肾虚咳喘、咯血、腰膝酸痛、阳痿早泄、遗精、病后久虚、自汗、盗汗等虚证。
红枣味甘性温、归脾胃经,有补中益气、养血安神、缓和药性的功能。中医的方子里,常常见到它的踪影,因为红枣既有缓和药性减少副作用,并保护正气的功能又能补气养血,是很好的营养保健品。根据现代科学分析,红枣含有丰富的蛋白质、脂肪、糖类、有机酸、胡萝卜素、维生素、部分矿物质钙、磷、铁等。鲜枣肉每100克含有维生素300-600毫克,比苹果高15倍左右,因而有“鲜维生素丸”的绰号。红枣中所含的维生素C是一种活性很强的还原性抗氧化物质,参与体内的生理氧气还原过程,防止黑色素在体内慢性沉淀,可起到美容养颜的功效。
历代养生家、医学家都很看重枸杞的补养功效。早在《神农本草经》中就指出:久服坚筋骨;《名医别录》谓枸杞擅长“补益精气”;《食疗本草》也记载枸杞“能益人,去虚劳”。枸杞的性味甘平,中医认为,它能够滋补肝肾、益精明目和养血、增强人们的免疫力。对于现代人来说,枸杞最实用的功效就是抗疲劳和降低血压。此外,枸杞能够保肝、降血糖、软化血管、降低血液中的胆固醇、甘油三酯水平,对脂肪肝和糖尿病患者具有一定的疗效。据临床医学验证,枸杞还能治疗慢性肾衰竭。常吃枸杞可以美容,这是因为,枸杞可以提高皮肤吸收氧分的能力,另外,还能起到美白作用。
祖国医学认为,西洋参味甘、微苦、凉、归心、肺、肾经,功能补气养阴、清火生津。现代科学研究发现,西洋参含有多种人参皂甙、洋参多糖及少量挥发油、维生素及微量元素等成分。具有抗疲劳、抗缺氧、增强机体抗病能力及促进蛋白质合成等作用。还有提高红细胞内超氧化物歧化酶活性,具有养胃生津、抗衰老、延年益寿的功效。它药性和缓,性寒凉,和人参的温热峻补不同,四季皆宜,尤适于夏天服用。它广泛用于非处方药、健康食品及化妆品等方面。
《中国药典》记载毛诃子清热解毒,调和诸药,收敛养血。其果实的乙醇提取物中,含有β-谷甾醇、没食子酸、鞣花酸、没食子酸乙酯、诃子酸(Chehulagic acid,C(41)H(30)O(27))及糖类物质。通常作为配伍使用。
怀牛膝药效高,李时珍说它:′滋补之功,如牛之力。′牛膝气味苦酸平,主治寒湿痿痹、四肢拘挛,膝痛不可屈伸,逐血气,伤热火烂,久服轻身耐老。博爱的牛膝,长于补益肝肾,强腰膝以及活血、引血小行的作用
本保健品以中草药的特性以及配伍性为依据,筛选出上述本草植物为主要原料,按照一定的比例搭配,达到药效充分发挥,相辅相成的效果,并采用细胞破壁微粉技术,保证了人体的有效吸收。
目前已有的技术多是由冬虫夏草、西洋参、红枣、枸杞中一种或两种为原料的保健品,其搭配欠佳,且结构单一。而本品以上述四种原料按一定的比例进行配比,并采用先进的细胞破壁微粉技术,提高了原料的药效,保证了人体的有效吸收,其功效显著提高。
发明内容
本发明的目的在于对冬虫夏草、西洋参、红枣、枸杞、毛诃子、怀牛膝进行合理搭配,达到相辅相成,充分发挥各原料的功效。
本发明的技术方案是这样实现的:它是下述原料按质量百分比混合制备而成:冬虫夏草5~15%,西洋参10~20%,红枣10~40%,枸杞10~40%,毛诃子5~10%,怀牛膝10~15%。
本发明较好的技术方案是:它是下述原料按质量百分比混合制备而成:冬虫夏草10%,西洋参15%,红枣30%,枸杞30%,毛诃子7%,怀牛膝8%。
本发明的制备方法包括以下步骤:
(1)、先分别将冬虫夏草、西洋参、红枣、枸杞、毛诃子、怀牛膝冷冻干燥,至水分为10%以下取出,分别在干燥环境中用粉碎机粉碎至80目,取出用超微粉碎机粉碎至500目,物料温度控制在50℃以下;
(2)、将粉碎后的冬虫夏草、西洋参、红枣、枸杞、毛诃子、怀牛膝按质量百分比:冬虫夏草5~15%,西洋参10~20%,红枣10~40%,枸杞10~40%,毛诃子5~10%,怀牛膝10~15%用三维混合机混合均匀;
(3)、将混合均匀后的原料灭菌,灌装成胶囊。
冬虫夏草具有增强人体免疫力,补虚损,益精气的功效,枸杞滋补肝肾,益精明目和养血,对人体免疫力具有调节功能,西洋参具有抗疲劳、抗缺氧、宁神益智及清热生津、增强机体抗病能力及促进蛋白质合成等作用,红枣有补中益气、养血安神、缓和药性的功能,四味药材经过合理配比,达到相辅相成,共同促进的作用,使该保健品在滋身养气、增加人体免疫力、健脑安神方面效果显著。
红枣中所含的维生素C是一种活性很强的还原性抗氧化物质,参与体内的生理氧气还原过程,防止黑色素在体内慢性沉淀,配合以枸杞的提高皮肤吸收氧分的能力,使该保健品在美容养颜方面效果独特。
冬虫夏草、枸杞、西洋参、作为药食同源食材,基本无毒性及副作用,辅之以红枣及毛诃子的缓和药性及减少副作用的独特功效,保证了本产品无任何毒副作用,适合于长期服用。本发明将冬虫夏草、西洋参、红枣、枸杞、毛诃子、怀牛膝六味原料,科学搭配组方无任何毒副作用和刺激性,经组合搭配后的作用相辅相成,使其中的有效成分发挥更佳效果,可长期服用,滋身养气、增加人体免疫力、健脑安神、美容养颜。
具体实施方式
实施例1
按重量配比称取冬虫夏草10%,西洋参15%,红枣35%,枸杞25%,毛诃子5%,怀牛膝10%,分别冷冻干燥至水分低于10%,在干燥环境下进行粗粉碎,达到80目的粒度,然后分别用超微粉碎机粉碎至500目,将混合后的原料混合均匀,灭菌后填充成胶囊,即得本发明保健胶囊。服用方法:温水冲服,每日3次,每次2~3颗。
实施例2
按重量配比称取冬虫夏草10%,西洋参10%,红枣25%,枸杞40%,毛诃子5%,怀牛膝10%,分别冷冻干燥至水分低于10%,在干燥环境下进行粗粉碎,达到80目的粒度,然后用超微粉碎机粉碎至500目,将混合后的原料混合均匀,灭菌后填充成胶囊,即得本发明保健胶囊。服用方法:温水冲服,每日3次,每次2~3颗。
实施例3
按重量配比称取冬虫夏草5%,西洋参10%,红枣40%,枸杞35%,毛诃子5%,怀牛膝5%,分别冷冻干燥至水分低于10%,在干燥环境下进行粗粉碎,达到80目的粒度,然后用超微粉碎机粉碎至500目,将混合后的原料混合均匀,灭菌后填充成胶囊,即得本发明保健胶囊。服用方法:温水冲服,每日3次,每次2~3颗。
实施例4、称取冬虫夏草10%,西洋参10%,红枣30%,枸杞30%,毛诃子10%,怀牛膝10%,分别冷冻干燥至水分低于10%,在干燥环境下进行粗粉碎,达到80目的粒度,然后用超微粉碎机粉碎至500目,将混合后的原料混合均匀,灭菌后填充成胶囊,即得本发明保健胶囊。服用方法:温水冲服,每日3次,每次2~3颗。
实施例5、称取冬虫夏草10%,西洋参15%,红枣30%,枸杞30%,毛诃子7%,怀牛膝8%,分别冷冻干燥至水分低于10%,在干燥环境下进行粗粉碎,达到80目的粒度,然后用超微粉碎机粉碎至500目,将混合后的原料混合均匀,灭菌后填充成胶囊,即得本发明保健胶囊。服用方法:温水冲服,每日3次,每次2~3颗。
Claims (3)
1.一种滋身养气功能的保健胶囊,它是下述原料按质量百分比混合制备而成:冬虫夏草5~15%,西洋参10~20%,红枣10~40%,枸杞10~40%,毛诃子5~10%,怀牛膝10~15%。
2.根据权利要求1所述的一种滋身养气功能的保健胶囊,它是下述原料按质量百分比混合制备而成:冬虫夏草10%,西洋参15%,红枣30%,枸杞30%,毛诃子7%,怀牛膝8%。
3.一种滋身养气功能的保健胶囊的制备方法,它包括以下步骤:
(1)、先分别将冬虫夏草、西洋参、红枣、枸杞、毛诃子、怀牛膝冷冻干燥,至水分为10%以下取出,分别在干燥环境中用粉碎机粉碎至80目,取出用超微粉碎机粉碎至500目,物料温度控制在50℃以下;
(2)、将粉碎后的冬虫夏草、西洋参、红枣、枸杞、毛诃子、怀牛膝按质量百分比:冬虫夏草5~15%,西洋参10~20%,红枣10~40%,枸杞10~40%,毛诃子5~10%,怀牛膝10~15%用三维混合机混合均匀;
(3)、将混合均匀后的原料灭菌,灌装成胶囊。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009102726498A CN102048151B (zh) | 2009-11-03 | 2009-11-03 | 一种滋身养气功能的保健胶囊及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009102726498A CN102048151B (zh) | 2009-11-03 | 2009-11-03 | 一种滋身养气功能的保健胶囊及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102048151A true CN102048151A (zh) | 2011-05-11 |
CN102048151B CN102048151B (zh) | 2013-03-27 |
Family
ID=43953219
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009102726498A Expired - Fee Related CN102048151B (zh) | 2009-11-03 | 2009-11-03 | 一种滋身养气功能的保健胶囊及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102048151B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104839689A (zh) * | 2015-04-21 | 2015-08-19 | 吉林大学珠海学院 | 一种健脾养胃、抗疲劳和提高免疫力作用的保健品 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1374392A (zh) * | 2001-03-13 | 2002-10-16 | 张振杰 | 一种保健营养补酒 |
CN1186438C (zh) * | 2003-09-26 | 2005-01-26 | 岳天文 | 保健养生酒及其制造方法 |
CN100374538C (zh) * | 2006-01-09 | 2008-03-12 | 刘景春 | 五脏滋补酒及其制备工艺 |
CN101530548B (zh) * | 2009-04-03 | 2011-06-22 | 李真子 | 一种具有多种保健功能的组合物及其制备方法 |
-
2009
- 2009-11-03 CN CN2009102726498A patent/CN102048151B/zh not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104839689A (zh) * | 2015-04-21 | 2015-08-19 | 吉林大学珠海学院 | 一种健脾养胃、抗疲劳和提高免疫力作用的保健品 |
Also Published As
Publication number | Publication date |
---|---|
CN102048151B (zh) | 2013-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102965235B (zh) | 一种板栗养生酒 | |
CN104856009A (zh) | 一种杜仲雄花保健品 | |
CN105265990A (zh) | 一种铁皮石斛复方保健酵素饮品及其制备方法 | |
US10987396B2 (en) | Composition for improving internal circulation and delaying aging and application thereof | |
CN103099833A (zh) | 有助于缓解运动疲劳和延缓衰老的软胶囊及其制备方法 | |
CN102940219B (zh) | 一种土豆饼及其制作方法 | |
CN101869287A (zh) | 芪蜂软胶囊及其制备方法 | |
CN103549437A (zh) | 一种降压降脂保健食品及其制备方法 | |
CN101401651A (zh) | 烹调用的中药组合物 | |
CN103798434A (zh) | 保健袋泡茶及其制备方法 | |
CN109527577A (zh) | 一种具有解酒护肝功能的组合物 | |
CN102048151B (zh) | 一种滋身养气功能的保健胶囊及其制备方法 | |
CN100506085C (zh) | 一种能够提高产妇免疫力的红糖保健品 | |
CN107080781A (zh) | 一种儿童补益壮骨调理增高的外用复方精油组合物 | |
CN105661496A (zh) | 一种高丽红参白芷细胞破壁超微粉的制备方法 | |
CN104187264B (zh) | 一种提高人体免疫力的营养组合物及其制备方法 | |
CN103637272B (zh) | 一种适合秋冬进补的莲子粉 | |
CN102224894B (zh) | 当归养生酒及其制备方法 | |
CN105832868A (zh) | 花椒斑蝥富硒药酒泡制方法 | |
CN106509578A (zh) | 即食型灵芝、茯苓复合健康饮品的生产方法 | |
CN105497519A (zh) | 一种高丽红参阿胶细胞破壁超微粉的制备方法 | |
CN105595336A (zh) | 一种高丽红参枸杞子细胞破壁超微粉的制备方法 | |
CN106421173A (zh) | 一种供顽固性头痛患者食用的保健食品及其制备方法 | |
CN105802816A (zh) | 花椒鹿茸草富硒药酒泡制方法 | |
CN106074333A (zh) | 一种破壁灵芝孢子粉蜂毒蜂蜜蜂胶面霜及其生产方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130327 Termination date: 20141103 |
|
EXPY | Termination of patent right or utility model |